Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick S Buckner

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Antimicrobial Agents and Chemotherapy|March 23, 2021
Spontaneous Selection of <i>Cryptosporidium</i> Drug Resistance in a Calf Model of InfectionMuhammad M Hasan, Erin E Stebbins, Robert K M Choy, et al.
Antimicrobial Agents and Chemotherapy|February 13, 2019
Optimization of Methionyl tRNA-Synthetase Inhibitors for Treatment of <i>Cryptosporidium</i> InfectionFrederick S Buckner, Ranae M Ranade, J Robert Gillespie, et al.
Journal of Molecular Biology|January 15, 2010
The crystal structure and activity of a putative trypanosomal nucleoside phosphorylase reveal it to be a homodimeric uridine phosphorylaseEric T Larson, Devaraja G Mudeppa, J Robert Gillespie, et al.
Antimicrobial Agents and Chemotherapy|July 4, 2007
Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferaseWesley C Van Voorhis, Kasey L Rivas, Pravin Bendale, et al.
Journal of Structural Biology|March 30, 2010
Prediction of protein crystallization outcome using a hybrid methodFrank H Zucker, Christine Stewart, Jaclyn dela Rosa, et al.
Nature Structural & Molecular Biology|May 4, 2010
Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitorsKayode K Ojo, Eric T Larson, Katelyn R Keyloun, et al.
Current Topics in Medicinal Chemistry|November 26, 2009
Fragment-based cocktail crystallography by the medical structural genomics of pathogenic protozoa consortiumChristophe L M J Verlinde, Erkang Fan, Sayaka Shibata, et al.
Proteins|December 14, 2005
Crystal structure of glyceraldehyde-3-phosphate dehydrogenase from Plasmodium falciparum at 2.25 A resolution reveals intriguing extra electron density in the active siteMark A Robien, Jürgen Bosch, Frederick S Buckner, et al.
Journal of Medicinal Chemistry|September 29, 2006
Using fragment cocktail crystallography to assist inhibitor design of Trypanosoma brucei nucleoside 2-deoxyribosyltransferaseJürgen Bosch, Mark A Robien, Christopher Mehlin, et al.
Nature Reviews. Drug Discovery|October 18, 2008
Genomic-scale prioritization of drug targets: the TDR Targets databaseFernán Agüero, Bissan Al-Lazikani, Martin Aslett, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Antimicrobial Agents and Chemotherapy|March 23, 2021
Spontaneous Selection of <i>Cryptosporidium</i> Drug Resistance in a Calf Model of InfectionMuhammad M Hasan, Erin E Stebbins, Robert K M Choy, et al.
Antimicrobial Agents and Chemotherapy|February 13, 2019
Optimization of Methionyl tRNA-Synthetase Inhibitors for Treatment of <i>Cryptosporidium</i> InfectionFrederick S Buckner, Ranae M Ranade, J Robert Gillespie, et al.
Journal of Molecular Biology|January 15, 2010
The crystal structure and activity of a putative trypanosomal nucleoside phosphorylase reveal it to be a homodimeric uridine phosphorylaseEric T Larson, Devaraja G Mudeppa, J Robert Gillespie, et al.
Antimicrobial Agents and Chemotherapy|July 4, 2007
Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferaseWesley C Van Voorhis, Kasey L Rivas, Pravin Bendale, et al.
Journal of Structural Biology|March 30, 2010
Prediction of protein crystallization outcome using a hybrid methodFrank H Zucker, Christine Stewart, Jaclyn dela Rosa, et al.
Nature Structural & Molecular Biology|May 4, 2010
Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitorsKayode K Ojo, Eric T Larson, Katelyn R Keyloun, et al.
Current Topics in Medicinal Chemistry|November 26, 2009
Fragment-based cocktail crystallography by the medical structural genomics of pathogenic protozoa consortiumChristophe L M J Verlinde, Erkang Fan, Sayaka Shibata, et al.
Proteins|December 14, 2005
Crystal structure of glyceraldehyde-3-phosphate dehydrogenase from Plasmodium falciparum at 2.25 A resolution reveals intriguing extra electron density in the active siteMark A Robien, Jürgen Bosch, Frederick S Buckner, et al.
Journal of Medicinal Chemistry|September 29, 2006
Using fragment cocktail crystallography to assist inhibitor design of Trypanosoma brucei nucleoside 2-deoxyribosyltransferaseJürgen Bosch, Mark A Robien, Christopher Mehlin, et al.
Nature Reviews. Drug Discovery|October 18, 2008
Genomic-scale prioritization of drug targets: the TDR Targets databaseFernán Agüero, Bissan Al-Lazikani, Martin Aslett, et al.
Pageof 12